Search
Respiratory Syncytial Virus (RSV) is a year-round threat to the health of babies and young children, and one of the leading causes of infant hospitalisation in Australia. It is highly contagious and can cause anything from mild cold-like symptoms to severe lung infections such as bronchiolitis and pneumonia. For n
Australia’s new respiratory syncytial virus (RSV) immunisation program cut hospital admissions for Australia’s youngest babies by almost half in its first year, a new major national study has shown.
An alarming number of Strep A infections are going unnoticed throughout classrooms in Broome and Derby according to a major study by The Kids Research Institute Australia aiming to reduce the burden of acute rheumatic fever (ARF) and rheumatic heart disease (RHD).
Valuable support from the Raine Medical Research Foundation’s 2025 grant round will power four new research projects at The Kids Research Institute Australia.
Efforts to improve health outcomes for Aboriginal children have been accelerated thanks to almost $1 million in National Health and Medical Research Council (NHMRC) funds awarded to skin health researchers at The Kids Research Institute Australia.
Researchers from The Kids Research Institute Australia will share in almost $4 million in grants to continue groundbreaking research to tackle childhood cancer, asthma, respiratory viral infections and more.
Researchers developing a nasal therapy to prevent childhood ear infections and reduce overuse of antibiotics have received $300,000 in top-up funding.
Painful ear infections and muffled sounds are a thing of the past for 100 Aboriginal children who have received free grommet surgery thanks to the Djaalinj Waakinj (listening and hearing) Ear Health program.
Researchers from the Wesfarmers Centre of Vaccines and Infectious Diseases, based at The Kids Research Institute Australia, are partnering with Down Syndrome WA to learn more about how respiratory syncytial virus, or RSV, affects children with increased medical vulnerability.
An Australian-first study demonstrating the effectiveness of a new immunisation against respiratory syncytial virus (RSV) for babies found it to be almost 90 per cent effective in reducing hospitalisation rates and helped more than 500 WA families avoid a hospital stay.